Microplate for imaging and metabolic analysis of cell samples

WO2026213320A3PCT designated stage Publication Date: 2026-11-12AGILENT TECHNOLOGIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/021938
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-03
Filing Date
2026-04-01
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing microplates struggle to obtain high-quality images and metabolic measurements of three-dimensional cell samples, such as spheroids, islets, and organoids, due to challenges in imaging and analyzing these complex structures.

Method used

The development of imaging microplates with specialized well geometry and transparent thin-film bottoms, designed for compatibility with XF analyzers, allows for high-resolution imaging and metabolic measurements of three-dimensional cell samples, including features like thin-film well bottoms and black side-walls to enhance imaging capabilities.

Benefits of technology

Enables stable culture and high-resolution imaging of three-dimensional cell samples, facilitating metabolic rate measurements without isolation or transfer, and supports optimized workflows for imaging and metabolic analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026021938_12112026_PF_FP_ABST
    Figure US2026021938_12112026_PF_FP_ABST
Patent Text Reader

Abstract

Microplates for imaging and metabolic analysis of a three-dimensional cell sample have a plurality of wells with transparent well surfaces so that cell samples in the wells are imaged from below the wells. Each of the walls of the wells includes a reservoir wall section adjacent to a bottom end, a shoulder section adjacent to the reservoir wall section, and a tapered wall adjacent the shoulder section. Methods of making and using the microplates are also provided.
Need to check novelty before this filing date? Find Prior Art

Description

Attorney Docket No. : AGT-20-PCT (20240122-02) MTCROPLATE FOR IMAGING AND METABOLIC ANALYSIS OF CELL SAMPLESCROSS-REFERENCE TO RELATED APPLICATIONS

[0001] The present application claims the benefit of and priority to US Provisional Patent Application No. 63 / 783,037 having a filing date of April 3, 2025, which is incorporated herein in its entirety by reference thereto.FIELD OF THE INVENTION

[0002] The present disclosure relates to microplates for imaging and metabolic analysis of cell samples. The present disclosure also relates to methods of manufacturing microplates.BACKGROUND OF THE INVENTION

[0003] Microplates are widely used for obtaining images and / or microscopic measurements of cells and other samples, and they are commercially available in a variety of well formats. Imaging microplates for cell cultures are available in 6-, 8-, 12-, 24-, 48-, 96-, 384- and 1536-well formats, and coated and non-coated plates are available for adherent cell cultures and suspension cultures.

[0004] Imaging microplates are often used for conducting measurements on cell populations. Typically, cells are seeded into a well of a microplate by pipetting an aqueous medium comprising cells into the well, and the cells settle on the bottom surface of the well. The seeded microplate is often placed into an incubator to promote cellular growth and expansion. This results in cells covering some or all of the bottom surface of the well. However, there are challenges that arise when trying to obtain high-quality images of cells seeded on the bottom surface of a well.20240122-01 / 027644-8504

[0005] The XF96 “Extracellular Flux Analyzer” was launched in 2008 by Seahorse Biosciences. Since that time the analyzer has been adopted for making quantitative measurements of mitochondrial function and cellular bioenergetics. The Seahorse XF analyzer can measure the concentrations of various analytes (02, H+, CO2) in the extracellular medium of a cell based assay. Analyte concentrations can be measured non-invasively, within a small volume about the cells, providing quantitative measurements for changes in analyte concentrations as a function of time from which bioenergetic flux (example: dO2 / dt=oxygen consumption rate, dpH / dt=extracellular acidification rate) can be determined. The XF measurements generally are based on a method in which a small, temporary, measurement volume is created around the cells, or a sensor is placed in close proximity to the cells.Measurements under these conditions amplifies changes in concentrations, allowing highly sensitive, time resolved measurements to be collected from a set of optical sensors. Once measurement(s) is made, the plunger is lifted and the medium around the cells is restored to its original condition. This nondestructive method allows multiple measurements to be serially collected for a biological sample under various conditions.

[0006] By making metabolic measurements such as oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), a profile of the bioenergetic phenotype may be developed based on the substrate and pathway (glycolysis or oxidative phosphorylation) for generating energy and biosynthesis. The analyzer allows quantitative measurements of mitochondrial function and cellular bio-energetics of cells.

[0007] However, there remains a need in the art for apparatus and methods for obtaining high-quality images as well as metabolic measurements of three-dimensional cell samples, including aerobic metabolism, glycolysis and intermediary metabolism.20240122-01 / 027644-8504SUMMARY OF THE INVENTION

[0008] In one aspect, the present disclosure provides imaging microplates for cell samples including three-dimensional cell samples such as spheroids, islets, and organoids. In another aspect, the present disclosure provides systems for obtaining images and metabolic measurements of two-dimensional (2D) or three-dimensional (3D) cell samples. In yet another aspect, the present disclosure provides methods for making and using imaging microplates suitable for imaging and metabolic analysis of cell sample, including spheroids, islets, organoids, and other three-dimensional cell samples.

[0009] These and other features and advantages of the present apparatus and methods will be apparent from the following detailed description, in conjunction with the appended claims.BRIEF DESCRIPTION OF THE DRAWINGS

[0010] FIGs. 1 A through IF are views of an embodiment of the present imaging microplate.

[0011] FIG. 2 shows an embodiment of an imaging and analysis system comprising the present imaging microplate.

[0012] FIGs. 3A to 3E illustrate embodiments of the present imaging microplate used with a device for obtaining metabolic measurements.

[0013] FIGs. 4 through 8 illustrate some of the results obtained in the example below.

[0014] The present teachings are best understood from the following detailed description when read with the accompanying drawing figures. The features are not necessarily drawn to scale. Wherever practical, like reference numerals refer to like features.20240122-01 / 027644-8504 DETAILED DESCRIPTION OF THE INVENTION

[0015] It is to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting. The defined terms are in addition to the technical and scientific meanings of the defined terms as commonly understood and accepted in the technical field of the present teachings.

[0016] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present teachings, some exemplary methods and materials are now described. All patents and publications referred to herein are expressly incorporated by reference.

[0017] As used herein, the terms “a,” “an,” and “the” include both singular and plural referents, unless the context clearly dictates otherwise. Thus, for example, “a well” includes one well and plural wells.

[0018] As used herein, and in addition to their ordinary meanings, the terms “substantial” or “substantially” mean to within acceptable limits or degree to one having ordinary skill in the art.

[0019] The terms “approximately” and “about”, as used herein, mean to within an acceptable limit or amount to one having ordinary skill in the art. The term “about” generally refers to plus or minus 15% of the indicated number. For example, “about 10” may indicate a range of 8.5 to 11.5. For example, “approximately the same” means that one of ordinary skill in the art considers the items being compared to be the same. It should be understood that any of the values disclosed herein are also a disclosure of the approximate value (e.g., the disclosure of “0.10” shall also constitute a disclosure of “about 0.10”), and any disclosure of an approximate20240122-01 / 027644-8504 value is a disclosure of the value itself (e.g., the disclosure of “about 0.10” shall also constitute a disclosure of “0.10”), unless the context indicates otherwise. In the present disclosure, numeric ranges are inclusive of the numbers defining the range.

[0020] “Adj cent” as used herein means one element is next to, close to, or near another element. Adjacent can refer to elements that touch each other, are contiguous, or that share a structure or border, and / or to elements may or may not be in physical contact with each other.

[0021] An “analyte” as used herein means any substance undergoing analysis, such as cells, tissues, organelles, subcellular structures such as microtubules or cytoskeleton, molecules, or other components.

[0022] The term “liquid” as used herein means a material that generally conforms to the shape of its container while retaining a substantially constant volume independent of pressure. Liquid includes materials such as solutions, mixtures, dispersions, gels, suspensions and pastes.

[0023] The term “three-dimensional cell sample” as used herein means a sample that comprises cells at least in part in three dimensions (3D). A three-dimensional cell sample may include portions where the cells lie in two dimensions (e.g., a monolayers of cells), so long as another portion of the cell sample is in three dimensions. The term includes spheroids, islets, and organoids. Cells analyzed with the present method and apparatus can be live cells, fixed cells, adherent cells, nonadherent cells, lysed cells, or mixtures thereof.

[0024] Before the various embodiments are described, it is to be understood that the teachings of this disclosure are not limited to the particular embodiments described, and as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present teachings will be limited only by the appended claims.20240122-01 / 027644-8504Imaging Microplates For Cell Samples

[0025] As one aspect of the present disclosure, an imaging microplate for a cell sample is provided. The present disclosure provides imaging microplates that solve one or more problems of existing microplates. Researchers can stably culture three-dimensional cell samples, such organoids embedded in 3-dimensional matrix, which are thicker than 200 pm on XF Analyzercompatible plate to measure the metabolic rates and to collect high resolution microscopic images without isolating or transferring the organoids.

[0026] In some embodiments, the microplate comprises 24 wells with an inner-well geometry designed to contain cell samples comprising a three-dimensional matrix, for example cells embedded in a hydrogel. This microplate can be designed for compatibility with XF analyzers or other devices for the measurement of cellular oxygen consumption and extracellular acidification and can contain features such as a thin-film well bottom and black side-walls to enable plate reading and high resolution imaging of the cell samples. An important advantage of this embodiment is that it allows for users to measure metabolism in embedded 3-dimensional models. The microplates provide ample space within the well for large organoid models (e.g., up to 200 pm or more) and allow for the development of an optimized workflow. In comparison to other plates, the present imaging microplate has a thin transparent fdm (190 pm) well bottom which will allow for confocal microscopy and imaging (up to 60X magnification). The simplified well geometry and black provide enhanced imaging capabilities.

[0027] The imaging microplate comprises a frame having a frame surface and frame sides extending from the frame surface, and a plurality of wells. Each well has a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end. Each well20240122-01 / 027644-8504 also has a well surface at the bottom end. The top end of each of the wells is surrounded by the frame and defines a top well opening. Each of the walls of the wells comprises a reservoir wall section adjacent to the bottom end, a tapered wall section adjacent to the reservoir wall section, and an upper wall section adjacent the top end. In some embodiments, a second tapered wall section is between the (first) tapered wall section and the upper wall section. It is also contemplated that the walls can have additional wall sections, such as above or below the upper wall section and / or the tapered wall section(s).

[0028] FIG. 1 A is an isometric view of an embodiment of the present imaging microplate 100 having a frame 101 with frame sides 103 and a frame surface 104. The imaging microplate 100 has twenty-four wells 102 having top ends with top well openings for receiving samples. FIG. IB is a top view of the imaging microplate 100 which shows wells 102 and the frame surface 104. FIG. 1C is a cutaway view of the imaging microplate 100 along line C-C of FIG. IB. The top end 105 and bottom end 106 of the wells 102 can be seen, along with the walls 107 of the walls. The walls of each well can be circular, oval, square, rectangular, or another shape. In some embodiments, the walls have two, three, or more wall sections which differ from each other in their shapes or other properties.

[0029] FIG. ID is a view of detail D from FIG. C which shows the wall sections of one of the wells more closely. The well 102 has a top end 105, a bottom end 106, and several sections of well wall 107, including a reservoir wall section 108, a shoulder section 110, a first tapered wall section 112, an upper wall section 113 adjacent to the top end of 105 of the well, and a second tapered wall section 114. The well surface 109 is at the bottom end 106 of the well, and comprises a top well surface 111 facing the interior of the well 102 and a bottom well surface 115 facing the exterior of the well 102.20240122-01 / 027644-8504

[0030] FIG. IE is another view of detail D from FIG. 1C which shows properties of various wall sections of the wells in this embodiment. Hl is a height of a reservoir wall section 108, and W1 is a width or longest dimension of the well surface 109 at the bottom end 106 of the well 102. In some embodiments, the height (Hl) of a reservoir wall section 108 is at least 0.1 mm, or at least 0.25 mm, or at least 0.5 mm, or at least 0.6 mm, or at least 0.7 mm, or at least 0.75 mm, or at least 0.8 mm, or at least 0.9 mm, or at least 0.95 mm, or at least 1 mm; alternatively or additionally, the height (Hl) of a reservoir wall section 108 is at most 4 mm, or at most 3 mm, or at most 2.5 mm, or at most 2 mm, or at most 1.75 mm, or at most 1.5 mm, or at most 1.4 mm, or at most 1.3 mm, or at most 1.25 mm, or at most 1.2 mm, or at most 1.1 mm, or at most 1.05 mm, or at most 1 mm, or at most 0.95 mm, or at most 0.9 mm, or at most 0.8 mm, or at most 0.75 mm, or at most 0.7 mm, or at most 0.5 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for height (Hl), so long as the minimum is smaller than the maximum (e.g., from 0.5 mm to 2 mm).

[0031] In some embodiments, height (Hl) is the sum of height (Hl a) and height (Hlb) (shown in FIG. 3D), wherein Hla is a height from well surface to a top of cell sample or a matrix medium, or a highest selected level of the sample or matrix medium, and Hlb is a height from the top of cell sample, matrix medium, or selected level, to the shoulder section, or to a sensor or plunger is inserted into the well for conducting measurement. Hlb can be a size sufficient to provide a gap between sensors or a plunger and the cell sample, including a matrix material.

[0032] T1 is the thickness of a well surface 109 (for example, a transparent film) at the bottom of the well 102. The well surface 109 can be formed by attaching a transparent film to the bottom well opening formed by the well walls 107, or to the underside of the frame 101 defining the open bottoms, so that the transparent film serves as the well surface. In some embodiments,20240122-01 / 027644-8504 the thickness (Tl) of the well surface 109 is at least 0.02 mm, or at least 0.04 mm, or at least 0.06 mm, or at least 0.08 mm, or at least 0.1 mm, or at least 0.125 mm, or at least 0.15 mm, or at least 0.16 mm, or at least 0.17 mm, or at least 0.18 mm, or at least 0.19 mm, or at least 0.2 mm, or at least 0.21 mm, or at least 0.22 mm, or at least 0.23 mm, or at least 0.24 mm, or at least 0.25 mm, or at least 0.275 mm, or at least 0.3 mm, or at least 0.35 mm, or at least 0.4 mm, or at least 0.5 mm, or at least 0.6 mm; alternatively or additionally, the thickness (Tl) of the well surface 109 is at most 1 mm, or at most 0.9 mm, or at most 0.8 mm, or at most 0.7 mm, or at most 0.6 mm, or at most 0.5 mm, or at most 0.4 mm, or at most 0.3 mm, or at most 0.29 mm, or at most 0.28 mm, or at most 0.27 mm, or at most 0.26 mm, or at most 0.25 mm, or at most 0.24 mm, or at most 0.23 mm, or at most 0.22 mm, or at most 0.21 mm, at most 0.2 mm, or at most 0.19 mm, or at most 0.18 mm, or at most 0.17 mm, or at most 0.16 mm, or at most 0.15 mm, or at most 0.125 mm, or at most 0.1 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for thickness (Tl), so long as the minimum is smaller than the maximum (e.g., from 0.1 mm to 0.3 mm).

[0033] DI is a distance between a bottom 115 of the well surface 109 (a surface of a transparent film opposite to the surface forming the well) and an end 116 of frame side 103. Distance DI enables the microplate to rest on a support without having the bottom 115 of the well surface 109 contact the support. This is advantageous to protect a transparent film from damage (e.g., puncture, scuffing) by contact with the support. In some embodiments, the distance (DI) is at least 0.02 mm, or at least 0.04 mm, or at least 0.06 mm, or at least 0.08 mm, or at least 0.1 mm, or at least 0.125 mm, or at least 0.15 mm, or at least 0.16 mm, or at least 0.17 mm, or at least 0.18 mm, or at least 0.19 mm, or at least 0.2 mm, or at least 0.21 mm, or at least 0.22 mm, or at least 0.23 mm, or at least 0.24 mm, or at least 0.25 mm, or at least 0.275 mm, or at least 0.320240122-01 / 027644-8504 mm, or at least 0.35 mm, or at least 0.4 mm, or at least 0.5 mm, or at least 0.6 mm; alternatively or additionally, the distance (DI) is at most 1 mm, or at most 0.9 mm, or at most 0.8 mm, or at most 0.7 mm, or at most 0.6 mm, or at most 0.5 mm, or at most 0.4 mm, or at most 0.3 mm, or at most 0.29 mm, or at most 0.28 mm, or at most 0.27 mm, or at most 0.26 mm, or at most 0.25 mm, or at most 0.24 mm, or at most 0.23 mm, or at most 0.22 mm, or at most 0.21 mm, at most 0.2 mm, or at most 0.19 mm, or at most 0.18 mm, or at most 0.17 mm, or at most 0.16 mm, or at most 0.15 mm, or at most 0.125 mm, or at most 0.1 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for distance (DI), so long as the minimum is smaller than the maximum (e.g., from 0.1 mm to 0.3 mm).

[0034] FIG. IF is another view of detail D from FIG. 1C. In some embodiments, the imaging microplate 100 is configured to receive a heater 117 between the wells of the well plate, so that the temperature of the wells can be increased, adjusted, or controlled to a desired setpoint. The underside of the wells can be shaped to substantially conform to the heater 117 (which is shown for illustrative purposes only in FIG. IF). A cell imaging and analysis system can have multiple heaters for contacting the wells of a well plate. In some embodiments, the heater 117 is configured to receive many well plate designs. In some embodiments, an environmental control unit can control the temperature of the wells, or a combination of heater 117 and an environmental control unit can be employed. In other embodiments, the sample can be cooled, or have other parameters (hypoxia, or CO2, humidity, etc.) adjusted by the environmental control unit.

[0035] The imaging microplate has well surfaces that are transparent. In some embodiments, the well surface is a thin transparent polystyrene film, with light transmission comparable to glass-bottom plates and adapted for delivering favorable imaging characteristics in widefield and20240122-01 / 027644-8504 confocal microscopy. The well surfaces can be also formed from materials such as glass, cyclic olefin copolymers, polycarbonate resins, and polyethylene terephthalate resins. In some embodiments, the transparent film or well surface has a thickness of about 500 pm or less, alternatively of about 400 pm or less, alternatively of about 300 pm or less, alternatively of about 250 pm or less, alternatively of about 200 pm or less, alternatively of about 190 pm or less, alternatively of about 175 pm or less, alternatively of about 150 pm or less; alternatively or additionally, the transparent film has a thickness of about 50 pm or more, alternatively of about 75 pm or more, alternatively of about 100 pm or more, alternatively of about 150 pm or more. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for the transparent film thickness, so long as the minimum is smaller than the maximum (e g., from about 100 pm to about 200 pm).

[0036] In some embodiments, the W1 is a width (or longest dimension) of the well surface 109 is at least 0.5 mm, or at least 1 mm, or at least 1.5 mm, or at least 2 mm, or at least 2.5 mm, or at least 3 mm, or at least 3.5 mm, or at least 3.75 mm, or at least 3.9 mm, or at least 4 mm, or at least 4.5 mm, or at least 5 mm, or at least 6 mm; alternatively or additionally, the width or longest dimension (Wl) of a well surface 109 is at most 16 mm, or at most 12 mm, or at most 10 mm, or at most 9 mm, or at most 8 mm, or at most 7 mm, or at most 6.5 mm, or at most 6.25 mm, or at most 6 mm, or at most 5.75 mm, or at most 5.5 mm, or at most 5 mm, or at most 4.5 mm, or at most 4.25 mm, or at most 4.1 mm, or at most 4 mm, or at most 3.75, or at most 3.5 mm, or at most 2 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for width or longest dimension (Wl), so long as the minimum is smaller than the maximum (e.g., from 1.5 mm to 6 mm).20240122-01 / 027644-8504

[0037] W2 is a width of the shoulder section 110, that is, the width of the wall section having a doughnut shape with an opening to the reservoir. In some embodiments, the width (W2) of the well opening is at least 0.1 mm, or at least 0.25 mm; or at least 0.5 mm; or at least 0.7 mm, or at least 0.8 mm, or at least 0.9 mm, or at least 0.95 mm, or at least 1 mm; or at least 1.1 mm, or at least 1.5 mm, or at least 2 mm, or at least 3 mm; alternatively or additionally, the width (W2) of the well opening is at most 6 mm, or at most 4 mm, or at most 2 mm, or at most 1.5 mm, or at most 1.3 mm, or at most 1.2 mm, or at most 1.1 mm, or at most 1.05 mm, or at most 1 mm, or at most 0.9 mm, or at most 0.75 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for width or longest dimension (W2), so long as the minimum is smaller than the maximum (e.g., from 0.5 mm to 2 mm).

[0038] W3 is a width or longest dimension of a top well opening. In some embodiments, the width (W3) of the top well opening is at least 5 mm, or at least 6 mm, or at least 7 mm, or at least 8 mm, or at least 9 mm, or at least 10 mm, or at least 11 mm, or at least 12 mm, or at least 13 mm, or at least 14 mm, or at least 15 mm, or at least 16 mm, or at least 17 mm, or at least 18 mm; alternatively or additionally, the width or longest dimension (W3) of the top well opening is at most 16 mm, or at most 16.5 mm, or at most 117 mm, or at most 17.25 mm, or at most 17.5 mm, or at most 17.75 mm, or at most 18 mm, or at most 18.25 mm, or at most 18.5 mm, or at most 18.75 mm, or at most 19 mm, or at most 20 mm, or at most 21 mm, or at most 22 mm; or at most 25 mm; or at most 30 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for width or longest dimension (W3), so long as the minimum is smaller than the maximum (e.g., from 16 mm to 20 mm).

[0039] Al is an angle of a tapered wall section 112 relative to a shoulder section 110 of the well or to an axis parallel to the well surface. In some embodiments, angle Al is at least 9020240122-01 / 027644-8504 degrees, or at least 95 degrees, or at least 100 degrees, or at least 101 degrees, or at least 102 degrees, or at least 103 degrees, or at least 104 degrees, or at least 105 degrees, or at least 106 degrees, or at least 107 degrees, or at least 108 degrees, or at least 109 degrees, or at least 110 degrees, or at least 111 degrees, or at least 112 degrees, or at least 113 degrees, or at least 114 degrees, or at least 115 degrees, or at least 120 degrees, or at least 135 degrees; alternatively or additionally, angle Al is at most 160 degrees, or at most 150 degrees, or at most 140 degrees, or at most 135 degrees, or at most 130 degrees, or at most 125 degrees, or at most 120 degrees, or at most 119 degrees, or at most 118 degrees, or at most 117 degrees, or at most 116 degrees, or at most 115 degrees, or at most 114 degrees, or at most 113 degrees, or at most 112 degrees, or at most 111 degrees, or at most 110 degrees, or at most 109 degrees, or at most 108 degrees, or at most 107 degrees, or at most 106 degrees, or at most 105 degrees, or at most 104 degrees, or at most 103 degrees, or at most 102 degrees, or at most 101 degrees, or at most 100 degrees. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for angle Al, so long as the minimum is smaller than the maximum (e.g., from 100 to 120 degrees).

[0040] A2 is an angle of a second tapered wall section 114 relative to a shoulder section 110 of the well or to an axis parallel to the well surface. In some embodiments, angle A2 is at least 115 degrees, or at least 120 degrees, or at least 125 degrees, or at least 126 degrees, or at least 127 degrees, or at least 128 degrees, or at least 129 degrees, or at least 130 degrees, or at least 131 degrees, or at least 132 degrees, or at least 133 degrees, or at least 134 degrees, or at least 135 degrees, or at least 136 degrees, or at least 137 degrees, or at least 138 degrees, or at least 139 degrees, or at least 140 degrees, or at least 141 degrees, or at least 142 degrees, or at least 143 degrees, or at least 144 degrees, or at least 145 degrees, or at least 150 degrees; alternatively20240122-01 / 027644-8504 or additionally, angle A2 is at most 180 degrees, or at most 170 degrees, or at most 180 degrees, or at most 155 degrees, or at most 150 degrees, or at most 145 degrees, or at most 144 degrees, or at most 143 degrees, or at most 142 degrees, or at most 141 degrees, or at most 140 degrees, or at most 139 degrees, or at most 138 degrees, or at most 137 degrees, or at most 136 degrees, or at most 135 degrees, or at most 134 degrees, or at most 133 degrees, or at most 132 degrees, or at most 131 degrees, or at most 130 degrees, or at most 129 degrees, or at most 128 degrees, or at most 127 degrees, or at most 126 degrees, or at most 125 degrees, or at most 120 degrees. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for angle A2, so long as the minimum is smaller than the maximum (e.g., from 120 to 150 degrees).

[0041] In some embodiments, the height of the upper wall section 113 is at least 2 mm, or at least 3 mm, or at least 4 mm, or at least 5 mm, or at least 6 mm, or at least 7 mm, or at least 8 mm; or at least 9 mm; or at least 10 mm; alternatively or additionally, the height of the upper wall section 113 is at most 10 mm, is at most 10.5 mm, or at most 11 mm, or at most 11.25 mm, or at most 11.5 mm, or at most 12 mm, or at most 13 mm, or at most 14 mm, or at most 15 mm, or at most 20 mm; or at most 25 mm; or at most 30 mm. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for the height of the upper wall section 113, so long as the minimum is smaller than the maximum (e.g., from 9 mm to 13 mm).

[0042] In some embodiments, the shoulder section 110 may comprise one or more centering features configured to center the probe (e.g. plunger 331 in FIG. 3) to be substantially concentric with the reservoir wall section. In one embodiment, the centering feature comprises a ramped rib 339 that slopes toward shoulder wall section 110.20240122-01 / 027644-8504

[0043] In some embodiments, the wall(s) of the wells (or one or more wall section(s)) are completely or partially opaque, in that they block transmission of light. More particularly, the upper wall section, and / or the tapered wall section, and / or the shoulder section, and / or the reservoir wall section can be opaque. The microplate can be formed from an opaque material, or the wall(s) of the wells can be painted or coated to render them opaque.

[0044] The imaging microplate can be formed from any suitable material which does not affect the imaging or measurement of a liquid sample and which has appropriate properties for manufacturing and use. Examples of materials include polyolefin-based or cyclic polyolefin-based resins such as norbomene polymers and copolymers, tetracyclodecene polymers and copolymers, and other polyolefin copolymers; polyethylene, polypropylene, ethyl ene-propylene copolymer; polystyrene-based resins such as polystyrene and acrylonitrile-butadiene-styrene-based resins; (meth)acrylic resins such as acrylic polymethacrylates, polymethylmethacrylates, and polyacrylonitriles, polycarbonate resins; polyethylene terephthalate resins; vinyl chloride resins; polybutylene terephthalate resins; polyacrylate resins; polysulfide resins; polyethersulfone resins; polyetheretherketone resins; polyetherimide resins; fluorine-based resins such as polytetrafluoroethylenes; polymethylpentene resin; and cellulosic resins.

[0045] In some embodiments, the well surface or other element has a diameter or longest dimension across its area. More particularly, when the well surface or other element is circular, its longest dimension is its diameter; when the well surface is oval, its longest dimension is its major axis; when the well surface or other element is a square or rectangular, its longest dimension is its diagonal connecting opposite corners; for other shapes, its longest dimension can be determined in a manner consistent the foregoing examples.20240122-01 / 027644-8504

[0046] In some embodiments, the reservoir wall section has a height which is from about 0.01 to about 2 of the diameter or longest dimension of the well surface. This can be advantageous for imaging a three dimensional cell sample. For example, for a well having a circular well surface of 4 mm and a reservoir wall section of 1 mm, the well has a reservoir wall section height that is 0.25 of the well surface diameter. Such a well can be employed for imaging an analyte in a sample having a low volume, such as 300 microliters (pL) or less. In some embodiments, the ratio of reservoir wall section height to well surface longest dimension can be a minimum of 0.01, 0.02, 0.05, 0.1, 0.15, 0.20, 0.21, 0.22, 0.23, 0.24, 0.25, 0.26, 0.27, 0.28, 0.29, 0.30, 0.35, 0.40 or 0.5. In some embodiments, the ratio of reservoir wall section height to well surface longest dimension can be a maximum of 2, 1.5, 1, 0.75, 0.5, 0.33, 0.3, 0.29, 0.28, 0.27, 0.20, 0.25, 0.24, 0.23, 0.22, 0.21, 0.2, 0.15, or O.10. It is contemplated that any of the foregoing minimums and maximums can be combined to form a range for the ratio, so long as the minimum is smaller than the maximum (e.g., from 0.1 to 0.5).

[0047] The imaging microplates of the present technology can be configured in any manner or orientation including to have dimensions that are consistent with the well number and spacing of standard imaging microplates. For example, in some embodiments, an imaging microplate of the present technology comprises at least 6 or at least 8 wells. In other embodiments, an imaging microplate of the present technology comprises at least 24 wells. In some embodiments, an imaging microplate of the present technology comprises at least 48 wells, or at least 96 wells, or at least 384 wells, or at least 1536 wells.Imaging And Analysis Systems Comprising An Imaging Microplate20240122-01 / 027644-8504

[0048] As another aspect of the present disclosure, imaging and analysis systems comprising the present imaging microplate are provided. The imaging and analysis systems comprise an imaging microplate as described herein. The systems also comprise a light source positionable above the imaging microplate, and / or a microscopic imager positionable below the imaging microplate, and / or a device for obtaining metabolic measurements. An exemplary embodiment of an imaging and analysis system comprising the present imaging microplate is depicted schematically in FIG. 2. The features are not drawn to scale. Generally, a light source is positioned, or can be moved into position, to irradiate the microplate as desired. In some embodiments, the light source is positioned below the microplate so that the cell samples within the wells are lit from below. Light can pass through the transparent well surface to irradiate the cell sample in the well. In some embodiments, the light source is positioned above the microplate so that the cell samples within the wells are lit from above (e.g., light can be directed into the well from the top opening. Light can pass through the top well openings, or through a transparent cover placed over the top well openings. In some embodiments, a microscopic imager is positioned, or can be moved into position, below the microplate so that the liquid sample is imaged from below the wells. However it is also contemplated that in some embodiments or situations, the positions of the light source and the microscopic imager may be reversed.

[0049] FIG. 2 shows a side cutaway view of the imaging microplate 200 (similar to that shown in FIG. 1C), with the X and Z dimensions visible. The imaging microplate 200 has a cell sample in a liquid medium in one or more of its wells. A light source 210 illuminates the microplate 200 from above or below the plate. The light source is selected based on the imaging desired and can be a point light source, a surface light source, a laser, or other illuminating20240122-01 / 027644-8504 device. In some embodiments, a white Light Emitting Diode (LED) is used. Other optical elements can be interposed between the light source 210 and the microplate 200 if desired. The illuminating of the wells by the light source can be carried out for individual wells or for the microplate as a whole. The light source 210 can be configured to move in an XY plane so that it is positioned over a particular well; alternatively or additionally, the imaging microplate 200 can be moved in an XY plane relative to the light source 210. The light source can be adapted for wide-field imaging and provide illumination for one or more of brightfield, color brightfield, phase contrast, fluorescent, phosphorescent, and other imaging modalities.

[0050] A microscopic imager 220 is positioned below the microplate 200 and configured to focus on one or more bottom ends of the wells in order to image or collect light from the well surfaces. The microscopic imager obtains an image or other data from the wells, usually on an individual basis. The focus of the microscopic imager 220 can be adjusted by vertically moving the microscopic imager 220 or a part thereof (such as an objective lens) in the Z dimension, so that is closer or farther from the bottom end of a well. In some embodiments, the microscopic imager 220 can be moved in an XY plane, optionally in coordination with the light source 210. Alternatively or additionally, the imaging microplate 200 can be moved in an XY plane relative to the microscopic imager 220. When a selected well 102 is imaged, the center of the well 102 can be positioned on the central axis of the light source 210 and microscopic imager 220. As a result, an illumination light path and an imaging light path are made consistent, and the illumination conditions are made constant, whereby the imaging conditions can be maintained well. Other optical elements can be interposed between the microscopic images 220 and the microplate 200 if desired.20240122-01 / 027644-8504

[0051] Examples of microscopic imagers 220 include inverted microscopes, which may be attached to a stage movable in the XY plane. The microscopic imager 220 can include multiple components for wide-field imaging and confocal imaging, such as objectives, lenses, LEDs, filter cubes, spinning disks, cameras and other components. In some embodiments, the imaging system comprises a video camera or other recording device to record the images of the liquid samples in the wells.

[0052] In some embodiments, the imaging system further comprises one or more controllers 240 in signal communication with (by wired or wireless means) the imaging microplate 200, the light source 210, the microscopic imager 220, the device 230 for obtaining metabolic measurements, or other components that hold or support them (such as a plate holder, a robotic arm, a gantry, or other actuator). The one or more controllers comprise, or are configured to receive and implement, one or more software programs for determining positions of the wells relative to the light source 210, the microscopic imager 220, and / or the device 230, and for moving one or more components to facilitate the imaging and / or analysis of the cell samples within the wells. The controller 240 may be, for example, a desktop computer, laptop computer, portable computer, tablet computer, handheld computer, mobile computing device, personal digital assistant (PDA), smartphone, etc., and may include one or more types of hardware (e.g., electronic-based processors, memories, user input peripherals, user output peripherals, etc.), firmware, and / or software. The imaging system may also include other electronics (not shown) configured for controlling movement or operation of the various components.

[0053] In some embodiments, the imaging system further comprises one or more devices 230 for obtaining metabolic measurements of the three-dimensional cell sample. Additional details20240122-01 / 027644-8504 about devices for obtaining metabolic measurements can be found in Teich et al. US Patent 9,170,253; McGarr et al. US Patent 9,494,577; and Taber US Pat. App. Pub. 20240159672A1.

[0054] FIG. 3A is a cross-sectional view of one embodiment of a three-dimensional cell sample contained in a well 302 of the present imaging well plate in association with a device 330 for obtaining metabolic measurements. FIG. 3B is a closer view of the bottom of the three-dimensional cell sample contained in the well 302 in FIG. 3A. The figures are for illustration and their features are not drawn to scale. The cross-sectional view of the device 330 shows a plunger 331 of the device lowered into the well 302. A reservoir is formed by the reservoir wall section 308 and the well surface 311 provided by a transparent film 311a attached to the bottom well opening. The reservoir contains a three-dimensional cell sample 316 contained in a liquid medium 333 that serves to hydrate the gel and submerge the distal end of the probe 331. In some embodiments, the cell sample comprises cells and a matrix medium such as a hydrogel. The cell sample 316 contains one or more analytes or metabolic parameters to be tested. In FIGs. 3 A and 3B, the plunger 331 is shown in association with the reservoir such that the plunger 331 is in contact with or close proximity to the shoulder section 310 three-dimensional cell sample 316. The plunger 331 is adapted to reciprocate between a lowered testing position, as shown in FIGs.3A and 3B, and a raised waiting position where the plunger is withdrawn from the reservoir. Lowering of the plunger 331 can be guided by the tapered wall section 312 adjacent to the shoulder section 310 or by other centering features such as ribs 339 (illustrated in FIG. 3E) where the wall is 314 is wider than the probe. As illustrated in FIGs. 3 A and 3B, the plunger 331 is adapted for lowering into the well 302 so as to form a measurement volume defined by the plunger 331, the reservoir wall section 308, and the well surface 311.20240122-01 / 027644-8504

[0055] In some embodiments, the device 330 comprises a cartridge that also includes one or more ports 332 adapted to deliver fluids such as liquids and gases into the well 302. For example, in one embodiment, the ports 332 can be in communication with an external gas supply 337 and an internal air control 338. The external gas supply 337 and the internal air control 338 can control gases fed to or removed from the head space above the liquid medium 333.

[0056] In addition to serving to reduce the volume for measurement, the plunger 331 can also serve as a probe. Plunger 331 in FIGs. 3A and 3B includes a plurality of fiber optics 334 that deliver excitation light to the cell sample 316 and transmit fluorescent emissions or phosphorescent emissions to an electrooptic sensor or other photodetection sensor. Examples of sensors include cameras, photodiodes, multi-pixel photon counters (MPPC), photomultiplier tubes (PMT), time-of-flight (TOF) sensors, combination of the foregoing and combinations with other sensors. In some embodiments, the parameter being tested for the cell sample 316 is autofluorescence, such as when a fluorophore is endogenous to the cell sample 316, and when fluorescent emission or phosphorescent emission occurs when illuminated with excitation light. The present methods and apparatus are also suited to producing images using fluorescence lifetime imaging microscopy (FLIM). In some embodiments, FLIM systems can be used to measure Fbrster / Fluorescence Resonant Energy Transfer (FRET) between labels comprising donor and acceptor fluorophores or a fluorophore and a quencher, or to obtain measurements of various metabolic parameters such as NAD(P)H. Alternatively, the present methods and apparatus can comprise contacting one or more fluorescent emission or phosphorescent emission agents, such as fluorophores, with the cell sample 316 or the liquid medium 333 that are influenced by the presence of a biological analyte when undergoing a fluorescent emission or phosphorescent emission. For example, as shown in FIG. 3A, the plunger 331 can include a pair20240122-01 / 027644-8504 of fluorophore sensors 335 and 336. The fluorophore sensors 335 and 336 can be the same or can be different for measuring different analytes or the same analyte under different conditions. The fluorophore sensors 335 and 336 can contain any suitable fluorophore or fluorescent agent that facilitates a fluorescent emission or phosphorescent emission.

[0057] FIG. 3C is another cross-sectional view of one embodiment of a three-dimensional cell sample contained in a well 302 of the present imaging well plate, and FIG. 3D is a closer view of the bottom of the three-dimensional cell sample contained in the well 302 in association with a plunger 331 for obtaining metabolic measurements. Well 302 contains liquid medium 333 and a cell sample 316 comprising organoids and a matrix material that serves as a scaffold for cells. In FIG. 3D, plunger 331 is lowered to contact the liquid medium 333 near the cell sample.

[0058] In some embodiments, the imaging microplates are configured for automated transport, incubation, and analysis in the imaging and analysis system. For example, the frame sides 103, frame surface 104, or other sections of the frame 101 can be configured to engage a robotic arm for automated transport or to fit within an incubator, plate reader, or storage environment.

[0059] In some embodiments, the imaging system comprises a microscopic imager capable of one or more, or all of, widefield imaging, confocal imaging, fluorescent imaging, and phosphorescent imaging.

[0060] In some embodiments, the system further comprises a heater. In some embodiments, the heater contacts the walls of the wells, and the exteriors of the walls of the well are configured for engaging the heater.Manufacturing An Imaging Microplate20240122-01 / 027644-8504

[0061] As another aspect of the present disclosure, methods of manufacturing an imaging microplate are provided. The methods comprise providing segments of a transparent fdm in a molding device configured to mold a microplate, wherein the segments have a size and shape the same as or consistent with the bottom well openings of the microplate. The transparent film can be a polystyrene, cyclic olefin polymer, or cyclic olefin co-polymer film having a thickness of about 200 pm or less, as described in more detail herein. In some embodiments, the discs of transparent film and the bottom of the frame are sized to conform with the area at the bottom of the well accommodate a heater.

[0062] The molding device is configured so that molding material will be molded (e.g., shaped or formed) into a microplate comprising (a) a frame having a frame surface and a frame side around the frame surface; and (b) a plurality of wells extending downward from the frame surface, each well having a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end, and the top end of each of the wells defines a top well opening, and the bottom end of each of the wells defines a bottom well opening.

[0063] The methods also comprise introducing a moldable material into the molding device so that the bottom well opening of each of the wells aligns with one of the discs. The moldable material can be a thermoplastic that solidifies by cooling, or a thermosetting material that solidifies by curing. Various polymers can be used as the moldable material for the manufacture of the microplate, such as cyclic olefin polymer or copolymer, polystyrene (PS), polyethylene (PE) or polypropylene (PP). The moldable material after solidification should be generally inert to samples or reagents typically encountered in cell culture or analysis, resistant to the absorption of biomolecules, and able withstand expected temperatures.20240122-01 / 027644-8504

[0064] In some embodiments, the frames are made using an over-molding injection process. Discs of transparent film are cut from 190 pm polymeric sheets which are placed in an injection molding tool. Then, the tool will inject liquid polymer (e.g. cyclic olefin polymer (COP), polystyrene, etc.) to form the frame, skirt, and walls of the plate while bonding to the film discs to form the bottom of each well. These plates can then be tissue culture treated and gammairradiated prior to providing them to an end user.

[0065] The molding device comprises a mold, typically constructed from a thermoset polymer or a metal such as steel, aluminum, or beryllium-copper alloy. Molds typically separate into at least two halves (called the core and the cavity) to permit the molded part to be extracted.

[0066] In some embodiments, the microplate can be molded by extruding the moldable material, which can be a mixture of a polymer and one or more thermally conductive additives. In some embodiments, the moldable material is heated above its melting point by the molding device and then injected or otherwise introduced into a mold cavity. The mold cavity is generally configured to define a desired shape of the microplate. The methods also comprise solidifying the moldable material such that the imaging microplate is formed with the segments of transparent film affixed to the bottom ends of each of the well. For instance, the molding device can cool the injected moldable material so that it solidifies, thereby creating the microplate. The microplate can be removed from the molding device.Methods of Imaging and Analyzing Three Dimensional Cell Samples

[0067] As another aspect of the present disclosure, methods are provided for imaging and analyzing three dimensional cell samples. The methods can comprise providing a three-dimensional cell sample into one or more of the wells of an embodiment of the present imaging20240122-01 / 027644-8504 microplates. A metabolic property of the three-dimensional cell sample is measured, and / or an image is obtained of the three-dimensional cell sample.

[0068] The present imaging well plates can be used to obtain images of the three dimensional cell samples or portions thereof such as cells, tissues, organelles, subcellular structures such as microtubules or cytoskeleton, molecules, or other components. In some embodiments, the methods comprise imaging live cells, fixed cells, adherent cells, nonadherent cells, lysed cells, or mixtures thereof. The present methods can provide high-quality high-resolution images of the three dimensional cell samples. The imaging microplates can be used for live cell imaging, fixation techniques, immunostaining, and standard fluorescence detection assays.

[0069] In some embodiments, the present methods comprise adding one or more cells to the wells of the imaging microplate. A cell composition comprising the cells (such as cells in a matrix medium such as a hydrogel) can be added by pipetting, injecting, or otherwise depositing into the well. In some embodiments, the composition has a volume of 300 pL or less, alternatively of 250 pL or less, alternatively of 200 pL or less, alternatively of 150 pL or less, alternatively of 100 pL or less, alternatively 50 pL or less, alternatively of 40 pL or less, alternatively of 30 pL or less, alternatively of 20 pL or less, alternatively of 10 pL or less.

[0070] Suitable hydrogels for culturing three-dimensional cell samples are permeable to dissolved oxygen, nutrients and metabolites of cells. Hydrogel can be an extracellular matrix based on the basement membrane of animal cells and can comprise laminin, collagen, fibronectin, proteoglycans, and / or polymers such as polyethylene glycol (PEG). Commercially available hydrogels include Coming™ Matrigel™ Matrix.

[0071] In some embodiments, the cells added to the wells are incubated for an incubation period before an image is obtained to form three-dimensional cell samples, such as spheroids,20240122-01 / 027644-8504 islets, or organoids. In some embodiments, the microplates seeded with cells can be moved to an incubator to incubate the cells. For example, an imaging microplate seeded with cells can be incubated for cell growth or expansion.

[0072] In some embodiments, a user suspends a cell culture in a hydrogel and pipettes up to a specified volume within the reservoir section (e g. up to 12 pL for a 1mm x 4mm reservoir section) of the mixture into the inner column of each well such that the upper level of the hydrogel leaves some space (e.g. 5% of the height) between the hydrogel and the sensors 335 of the probe 331. As the cell culture proliferates and (where appropriate) differentiates, organoids are formed within or on the gel. After a desired culturing period, the plates can be measured using a device for obtaining metabolic measurements, such as an XF instrument, to generate oxygen consumption and extracellular acidification results for the user. A user may also collect images of the samples using an imaging microscope.

[0073] In some embodiments, the present methods comprise contacting the cell sample or an analyte in the liquid medium with a label before obtaining the image. Examples of labels include chromophores, fluorophores, phosphors, quantum dots, luminescent or chemiluminescent molecules, radioisotopes, magnetic nanoparticles, and mass tags.

[0074] The methods comprise obtaining one or more images of the three-dimensional cell samples in the wells. The images can be viewed while being obtained and / or recorded for later viewing. In some embodiments, the methods and apparatus obtain brightfield images, color brightfield images, phase contrast images, fluorescent images, phosphorescent images, and / or images from other modalities.

[0075] The present methods can further comprise analysis of the cell sample or the obtained images of the cell samples, such as by analysis of cellular growth rate, cell morphology, nuclear20240122-01 / 027644-8504 morphology, cellular responses (such as to drugs or other stimuli), protein expression (such as receptor expression or cytokine expression), mRNA expression, metabolic properties, pH levels or changes, cellular waste products (such as carbon dioxide, water, lactic acid, urea, or ammonia), or a combination thereof. In some embodiments, cells from the imaging microplate have their nucleic acids (DNA and / or RNA) sequenced and analyzed.

[0076] In some embodiments, the well surface can have a structure or composition that enhances cell attachment, supports cell proliferation, promotes formation of a three dimensional cell sample, or otherwise facilitates cell culture. In some embodiments, the well surface has a coating disposed thereon.

[0077] In some embodiments, the present methods and apparatus are used for analytical measurements besides imaging. For example, they can be used for metabolic measurements of cells in a culture, such as overall cellular metabolic and respirative rates, mitochondrial respiration, measurements of glycolysis, adenosine triphosphate (ATP) production, relative proportion of aerobic to anaerobic respiration, relative rates of consumption of various metabolic substrates, effect of stimulation of certain transmembrane and other cellular receptors, rates of production of various secreted factors, and cell viability. In some embodiments, the metabolic measurements are OCR and / or ECAR.

[0078] In some embodiments, the present methods also include forming a measurement volume by lowering a plunger to contact the shoulder section, so that the volume is reduced. The reduced volume can be from about 0.5% to about 50% of the original volume of the well, alternatively from about 5% to about 20% of the original volume, alternatively less than about 5% of the original volume.20240122-01 / 027644-8504

[0079] In some embodiments, one or more sensors can be used to measure metabolic parameters of the cell sample in the wells of the imaging wall plate. In some embodiments, the sensor(s) are adapted for measuring one or more analytes in a liquid medium in contact with the cell sample. The sensors can be a fluorescent sensor, a luminescent sensor, an ISFET sensor, a surface plasmon resonance sensor, a sensor based on an optical diffraction principle, a sensor based on a principle of Wood’s anomaly, an acoustic sensor, or a microwave sensor. The present technology is not limited to any particular cellular assays, measurements or sensors. In some embodiments, the imaging microplates are used in conjunction with an optical fiber probe, such as probes used in the Agilent XF instruments.

[0080] The present methods and apparatus can be used in a variety of fields related to cell culture and analysis. Such fields include, but are not limited to, biological research, drug discovery, and clinical diagnostics. For example, as a drug discovery tool, the imaging microplates or imaging systems can be used to screen various molecules for an effect on cellular metabolism in co-culture, protein secretion, or intra / extra cellular ion exchange. The present methods and apparatus can also be used to determine the health of a cell sample in culture, including co-culture, both before and after a conventional assay is performed, thereby improving the performance of such an assay.Exemplary Embodiments

[0081] Embodiment 1. An imaging microplate comprising: (a) a frame having a frame surface and a frame side around the frame surface; (b) a plurality of wells extending downward from the frame surface, each well having a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end, and the top end of each of the wells defines a top well opening, and the bottom end of each of the wells defines a bottom well20240122-01 / 027644-8504 opening; and (c) a well surface at the bottom end of each of the wells, wherein the well surface is transparent; wherein each of said one or more walls comprises: (i) a reservoir wall section adjacent to the bottom end, wherein the reservoir wall section and the well surface form a reservoir; (ii) a shoulder section adjacent to the reservoir wall section; and (iii) a tapered wall section adjacent to the shoulder section, the tapered wall section having a depth greater than the reservoir wall section.

[0082] Embodiment 2. The imaging microplate of embodiment 1, wherein the well surface has a diameter or a longest dimension of from about 3 mm to about 6 mm, alternatively about 4 mm.

[0083] Embodiment 3. The imaging microplate of any of embodiments 1 to 2, wherein the reservoir wall section has a height from about 0.5 mm to about 2 mm, alternatively about 1 mm.

[0084] Embodiment 4. The imaging microplate of any of embodiments 1 to 3, wherein the well surface is circular and has a diameter of about 4 mm, and the reservoir wall section has a height of about 1 mm.

[0085] Embodiment 5. The imaging microplate of any of embodiments 1 to 4, wherein the well surface has a cross-sectional area of from 6 to 24 mm2, alternatively about 12 mm2.

[0086] Embodiment 6. The imaging microplate of any of embodiments 1 to 5, wherein some or all of the one or more walls is opaque.

[0087] Embodiment 7. The imaging microplate of any of embodiments 1 to 6, wherein the imaging microplate is formed from a thermoplastic material.

[0088] Embodiment 8. The imaging microplate of embodiment 7, wherein the thermoplastic material comprises polystyrene, polyethylene terephthalate (PET), polypropylene, polycarbonate, a cyclic olein polymer and / or a cyclic olefin copolymer.20240122-01 / 027644-8504

[0089] Embodiment 9. The imaging microplate of any of embodiments 1 to 8, wherein the well surface is covered by a coating.

[0090] Embodiment 10. The imaging microplate of any of embodiments 1 to 9, wherein the well surface is a polystyrene, cyclic olefin polymer, or cyclic olefin co-polymer film.

[0091] Embodiment 11. The imaging microplate of any of embodiments 1 to 10, wherein the well surface is transparent film attached to the bottom well opening.

[0092] Embodiment 12. The imaging microplate of embodiment 11, wherein the transparent film has a thickness of about 500 pm or less, or about 400 pm or less, or about 300 pm or less, or about 250 pm or less, or about 200 pm or less, or about 190 pm or less, or about 175 pm or less, or about 150 pm or less.

[0093] Embodiment 13. The imaging microplate of any of embodiments 1 to 12, wherein the tapered wall section is a first tapered wall section, and the wall further comprises: a second tapered wall section adjacent the first tapered wall section, having an angle from about 115 degrees to about 180 degrees, and an upper wall section adjacent the second tapered wall section, having an angle from about 80 to about 100 degrees relative to the well surface.

[0094] Embodiment 14 The imaging microplate of any of embodiments 1 to 13, wherein the reservoir has a volume of 300 pL or less.

[0095] Embodiment 15. The imaging microplate of any of embodiments 1 to 14, wherein the reservoir has a volume from about 6 pL to about 24 pL, alternatively about 12 pL.

[0096] Embodiment 16. The imaging microplate of any of embodiments 1 to 15, wherein the upper wall section has one or more of the following properties: a rectangular shape; a height that is about 75% or more of the total height of the wall of the well; or a substantially perpendicular orientation to the bottom end.20240122-01 / 027644-8504

[0097] Embodiment 17. The imaging microplate of embodiment 16, wherein the reservoir wall section is circular.

[0098] Embodiment 18. A method of manufacturing an imaging microplate, the method comprising: placing transparent fdm segments in a molding device configured to mold a microplate comprising: (a) a frame having a frame surface and a frame side around the frame surface; (b) a plurality of wells extending downward from the frame surface, each well having a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end, and the top end of each of the wells defines a top well opening, and the bottom end of each of the wells defines a bottom well opening; introducing a moldable material into the molding device so that the bottom well opening of each of the wells aligns with one of the transparent film segments; and solidifying the moldable material such that the imaging microplate is formed with the transparent film segments affixed to the bottom ends of each of the well.

[0099] Embodiment 19. The method of embodiment 18, wherein the transparent film segments are segments of a polystyrene film having a thickness of about 200 pm or less.

[0100] Embodiment 20. The method of any of embodiments 18 to 19, wherein the moldable material is a thermoplastic material.

[0101] Embodiment 21. The method of embodiment 20, wherein the thermoplastic material comprises a cyclic olefin polymer or a cyclic olefin copolymer.

[0102] Embodiment 22. The method of any of embodiments 18 to 21, wherein the moldable material is a thermosetting material.

[0103] Embodiment 23. The method of embodiment 22, wherein the method comprises contacting the cell sample with a label before obtaining the image.20240122-01 / 027644-8504

[0104] Embodiment 24. A method of analyzing a cell sample in a well, the method comprising: providing a cell sample into one or more of the wells of the imaging microplate of any one of embodiments 1 to 17; and obtaining a metabolic measurement of the cell sample; and / or obtaining an image of the cell sample.

[0105] Embodiment 25. The method of embodiment 24, wherein the cell sample is a three-dimensional cell sample.

[0106] Embodiment 26. The method of embodiment 25, wherein the three-dimensional cell sample comprises cells in a matrix medium.

[0107] Embodiment 27. The method of any of embodiments 24 to 26, wherein the cell sample is provided by adding one or more cells to the one or more wells, and expanding the one or more cells.

[0108] Embodiment 28. The method of any of embodiments 24 to 27, wherein the cell sample is in a liquid medium in the one or more wells.

[0109] Embodiment 29. The method of embodiment 28, wherein the method further comprises contacting the liquid medium with a sensor.

[0110] Embodiment 30. The method of any of embodiments 24 to 29, wherein the metabolic parameter is OCR and / or ECAR.

[0111] Embodiment 31. The method of any of embodiments 24 to 30, wherein further comprising forming a measurement volume by lowering a plunger to contact the shoulder section.

[0112] Embodiment 32. The method of embodiment 31, wherein the plunger does not contact the cell sample.20240122-01 / 027644-8504

[0113] Embodiment 33. The method of embodiment 31, wherein the measurement volume is from about 0.5% to about 50% of an original volume of the well.

[0114] Embodiment 34. A cell imaging and analysis system comprising: the imaging microplate of any one of embodiments 1 to 17; a light source positioned to irradiate the imaging microplate; a microscopic imager positioned below the imaging microplate and a device for obtaining metabolic measurements, positioned above the imaging microplate.

[0115] Embodiment 35. The system of embodiment 34, wherein the light source is adapted to irradiate the microplate with visible light.

[0116] Embodiment 36. The system of any of embodiments 34 to 35, wherein the light source is adapted to irradiate a single well of the microplate.

[0117] Embodiment 37. The system of any of embodiments 34 to 36, wherein the light source is positioned below the microplate.

[0118] Embodiment 38. The system of any of embodiments 34 to 36, wherein the light source is positioned above the microplate.

[0119] Embodiment 39. The system of any of embodiments 34 to 38, wherein the device for obtaining metabolic measurements comprises one or more plungers configured to move vertically down within the wells to the shoulder section.

[0120] Embodiment 40. The system of embodiment 39, wherein the one or more plungers are affixed to a cartridge.

[0121] Embodiment 41. The system of any of embodiments 34 to 40, further comprising a heater configured for applying heat to the wells through the walls of the wells.

[0122] The present disclosure may be better understood with reference to the following examples.20240122-01 / 027644-8504EXAMPLES

[0123] The following examples illustrate the performance advantages of the imaging microplate of the present disclosure. These examples demonstrate stable liquid retention compatibility with three-dimensional cell cultures (including organoids embedded in a hydrogel), high-resolution imaging capabilities (including bright-field, fluorescence, and confocal microscopy), metabolic flux analysis compatibility with analyzers, optical transparency of the thin-film well bottom, and effective prevention of inter-well light leakage. All data were obtained using microplates similar to those shown and described in FIGS. 1 A-1F, 2, and 3A-3E.Example 1 - Stable liquid retention and bright-field imaging compatibility

[0124] FIG. 4 shows bright-field well-images of a microplate made in accordance with the present disclosure. Each well retains water stably at a volume of 500 pL / well with no leakage or meniscus distortion. The wells are fully compatible with imaging-plate readers, confirming that the microplate supports standard bright-field imaging of aqueous samples without additional handling steps. Subpanels A-D illustrate representative wells under standard plate-reader conditions.Example 2 - Culture and high-resolution imaging of three-dimensional organoids

[0125] FIG. 5 demonstrates that organoids of varying sizes (up to 200 pm or larger) can be successfully cultured directly in the microplate of the present disclosure under Matrigel-embedded (hydrogel) conditions and imaged without isolation or transfer. Each panel shows a representative bright-field or fluorescence image of the indicated organoid type after the stated culture period. These results confirm that the thin-film well bottom (<190 pm cyclo-olefin polymer) and simplified well geometry enable both conventional and high-magnification confocal microscopy of three-dimensional samples.

[0126] FIG. 5A shows hepatic organoids cultured for 3 days in Matrigel-embedded condition. These organoids are derived from primary or stem-cell-derived liver cells (hepatocytes and associated biliary epithelial cells) and form compact, spherical structures that recapitulate basic liver architecture. The image illustrates stable embedding and growth within the reservoir section of the well, with clear cellular boundaries visible under standard bright-field illumination.20240122-01 / 027644-8504

[0127] FTG. 5B shows intestinal organoids cultured for 6 days in Matrigel -embedded condition. These organoids are derived from intestinal stem cells or epithelial cells and develop characteristic crypt-like budding structures that mimic small-intestine or colonic epithelium. The image demonstrates multi-cellular organization and lumen formation, confirming that the microplate supports prolonged 3D culture of polarized epithelial organoids without matrix disruption.

[0128] FIG. 5C shows cancer organoid cultured for 7 days in Matrigel-embedded condition, showing fluorescence (FL) imaging capabilities at 4* magnification. These organoids are patient-derived or cell-line-derived tumor organoids (e.g., from colorectal, pancreatic, or other solid tumors) that retain patient-specific genetic and phenotypic features. The fluorescence channel highlights labeled cells or structural components, demonstrating the microplate’s compatibility with fluorescent markers at low magnification for whole-organoid overview imaging.

[0129] FIG. 5D shows cancer organoids illustrating confocal imaging capabilities at 60* magnification. The same cancer organoid type as in FIG. 5C, now imaged at high resolution. The confocal z-stack capability reveals internal cellular architecture, nuclear morphology, and 3D organization within the thick (>200 pm) Matrigel-embedded sample. This confirms that the ultra-thin transparent well bottom permits high-numerical-aperture objective access without optical distortion or spherical aberration.

[0130] All four panels were acquired on the same microplate format, illustrating the versatility of the reservoir geometry (~12 pL working volume for the embedded matrix) and black side-walls for multi-modal imaging of diverse organoid models (hepatic, intestinal, and cancer-derived) in a single integrated workflow.Example 3 - Metabolic flux analysis compatibility

[0131] FIG. 6 shows that the microplate is fully compatible with the analyzer for quantitative measurements of cellular bioenergetics. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were successfully measured from both 2D cultured cells and three-dimensional organoids. The measured metabolic rates correlate closely with the amount of20240122-01 / 027644-8504biological sample present in each well, confirming that the reservoir geometry, transparent well bottom, and black sidewalls support accurate, non-invasive flux analysis of embedded organoid models without compromising sensor function or sample integrity.Example 4 - Optical transparency of the thin-film well bottom

[0132] FIG. 7 compares the optical transparency of the plate bottom of the microplate of the present disclosure, which is formed from a thin-film cyclo-olefin polymer (<190 pm thickness), with two commercial products: (i) the XF24 microplate (thick polystyrene bottom) and (ii) a standard 96-well microplate with a transparent bottom intended for plate-reader use. The present microplate exhibits superior optical clearance, enabling high-quality transmitted-light and fluorescence imaging through the bottom of the well while maintaining mechanical stability and compatibility with the sensor plungers.Example 5 - Prevention of inter-well light leakage by black sidewalls

[0133] FIG. 8 demonstrates the effectiveness of the black sidewalls in eliminating light leakage between adjacent wells. Columns 4 and 6 of a 24-well plate were loaded with a luminescent agent, and luminescence was measured across all columns. Luminescence was fully confined to the loaded columns; no detectable signal bleed occurred into neighboring columns, confirming that the opaque black sidewalls provide complete optical isolation needed for accurate fluorescence, luminescence, and confocal measurements in multi-well formats.

[0134] These examples collectively confirm that the imaging microplate enables an integrated workflow for three-dimensional cell samples (including organoids and other spheroids / islets) in which the same plate supports Matrigel-embedded culture, high-resolution imaging (bright-field, fluorescence, and confocal up to 60*), and direct metabolic flux analysis (OCR / ECAR) on an analyzer without any sample transfer steps. The thin-film transparent bottom, reservoir geometry sized for volumes <300 pL, and black sidewalls contribute to achieving these combined capabilities.

Claims

20240122-01 / 027644-8504CLAIMSWe claim:

1. An imaging microplate comprising:(a) a frame having a frame surface and a frame side around the frame surface;(b) a plurality of wells extending downward from the frame surface, each well having a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end, and the top end of each of the wells defines a top well opening, and the bottom end of each of the wells defines a bottom well opening; and(c) a well surface at the bottom end of each of the wells, wherein the well surface is transparent;wherein each of said one or more walls comprises:(i) a reservoir wall section adjacent to the bottom end, wherein the reservoir wall section and the well surface form a reservoir;(ii) a shoulder section adjacent to the reservoir wall section; and (iii) a tapered wall section adjacent to the shoulder section, the tapered wall section having a depth greater than the reservoir wall section.

2. The imaging microplate of claim 1, wherein the well surface has a diameter or a longest dimension of from about 3 mm to about 6 mm, alternatively about 4 mm.

3. The imaging microplate of claim 1, wherein the reservoir wall section has a height from about 0.5 mm to about 2 mm, alternatively about 1 mm.

4. The imaging microplate of claim 1, wherein the well surface is circular and has a diameter of about 4 mm, and the reservoir wall section has a height of about 1 mm.20240122-01 / 027644-85045. The imaging microplate of claim 1, wherein the well surface has a cross-sectional area of from 6 to 24 mm2, alternatively about 12 mm2.

6. The imaging microplate of claim 1, wherein some or all of the one or more walls is opaque.

7. The imaging microplate of claim 1, wherein the imaging microplate is formed from a thermoplastic material.

8. The imaging microplate of claim 7, wherein the thermoplastic material comprises polystyrene, polyethylene terephthalate (PET), polypropylene, polycarbonate, a cyclic olein polymer and / or a cyclic olefin copolymer.

9. The imaging microplate of claim 1, wherein the well surface is covered by a coating.

10. The imaging microplate of claim 1, wherein the well surface is a polystyrene, cyclic olefin polymer, or cyclic olefin co-polymer film.

11. The imaging microplate of claim 1, wherein the well surface is transparent film attached to the bottom well opening.

12. The imaging microplate of claim 11, wherein the transparent film has a thickness of about 500 pm or less, or about 400 pm or less, or about 300 pm or less, or about 250 pm or less, or about 200 pm or less, or about 190 pm or less, or about 175 pm or less, or about 150 pm or less.20240122-01 / 027644-850413. The imaging microplate of claim 1, wherein the tapered wall section is a first tapered wall section, and the wall further comprises:a second tapered wall section adjacent the first tapered wall section, having an angle from about 115 degrees to about 180 degrees, andan upper wall section adjacent the second tapered wall section, having an angle from about 80 to about 100 degrees relative to the well surface.

14. The imaging microplate of claim 1, wherein the reservoir has a volume of 300 pL or less.1 . The imaging microplate of claim 1 , wherein the reservoir has a volume from about 6 pL to about 24 pL, alternatively about 12 pL.

16. The imaging microplate of claim 1, wherein the upper wall section has one or more of the following properties:a rectangular shape;a height that is about 75% or more of the total height of the wall of the well; or a substantially perpendicular orientation to the bottom end.

17. The imaging microplate of claim 16, wherein the reservoir wall section is circular.

18. A method of manufacturing an imaging microplate, the method comprising: placing transparent film segments in a molding device configured to mold a microplate comprising:(a) a frame having a frame surface and a frame side around the frame surface;20240122-01 / 027644-8504 (b) a plurality of wells extending downward from the frame surface, each well having a top end, a bottom end opposite the top end, and one or more walls between the top end and the bottom end, and the top end of each of the wells defines a top well opening, and the bottom end of each of the wells defines a bottom well opening; introducing a moldable material into the molding device so that the bottom well opening of each of the wells aligns with one of the transparent film segments; andsolidifying the moldable material such that the imaging microplate is formed with the transparent film segments affixed to the bottom ends of each of the well.

19. The method of claim 18, wherein the transparent film segments are segments of a polystyrene film having a thickness of about 200 pm or less.

20. The method of claim 18, wherein the moldable material is a thermoplastic material.

21. The method of claim 20, wherein the thermoplastic material comprises a cyclic olefin polymer or a cyclic olefin copolymer.

22. The method of claim 18, wherein the moldable material is a thermosetting material.

23. The method of claim 22, wherein the method comprises contacting the cell sample with a label before obtaining the image.

24. A method of analyzing a cell sample in a well, the method comprising:20240122-01 / 027644-8504 providing a cell sample into one or more of the wells of the imaging microplate of any one of claims 1 to 17; andobtaining a metabolic measurement of the cell sample; and / orobtaining an image of the cell sample.

25. The method of claim 24, wherein the cell sample is a three-dimensional cell sample.

26. The method of claim 25, wherein the three-dimensional cell sample comprises cells in a matrix medium.

27. The method of claim 24, wherein the cell sample is provided by adding one or more cells to the one or more wells, and expanding the one or more cells.

28. The method of claim 24, wherein the cell sample is in a liquid medium in the one or more wells.

29. The method of claim 28, wherein the method further comprises contacting the liquid medium with a sensor.

30. The method of claim 24, wherein the metabolic parameter is OCR and / or ECAR.

31. The method of claim 24, wherein further comprising forming a measurement volume by lowering a plunger to contact the shoulder section.

32. The method of claim 31, wherein the plunger does not contact the cell sample.20240122-01 / 027644-8504 33. The method of claim 31, wherein the measurement volume is from about 0.5% to about 50% of an original volume of the well.

34. A cell imaging and analysis system comprising:the imaging microplate of any one of claims 1 to 17;a light source positioned to irradiate the imaging microplate;a microscopic imager positioned below the imaging microplate anda device for obtaining metabolic measurements, positioned above the imaging microplate.

35. The system of claim 34, wherein the light source is adapted to irradiate the microplate with visible light.

36. The system of claim 34, wherein the light source is adapted to irradiate a single well of the microplate.

37. The system of claim 34, wherein the light source is positioned below the microplate.

38. The system of claim 34, wherein the light source is positioned above the microplate.

39. The system of claim 34, wherein the device for obtaining metabolic measurements comprises one or more plungers configured to move vertically down within the wells to the shoulder section.

40. The system of claim 39, wherein the one or more plungers are affixed to a cartridge.20240122-01 / 027644-850441. The system of claim 34, further comprising a heater configured for applying heat to the wells through the walls of the wells.